By IDSE News Staff
Resistance to the new multidrug-resistant TB (MDR-TB) treatment regimen recently recommended by the WHO is already spreading among patients, according to researchers at the Swiss Tropical and Public Health Institute (Swiss TPH) (N Engl J Med 2025;392[1]:97 doi:10.1056/NEJMc2404644).
The findings highlight the urgent need for better surveillance and infection control to counteract the rise in antimicrobial resistance, they said.